Compliance with iron chelation therapy in beta thalassaemia

1998 ◽  
Vol 10 (8) ◽  
pp. 17-20 ◽  
Author(s):  
Vicky Vidler
1983 ◽  
Vol 3 (2) ◽  
pp. 99-101 ◽  
Author(s):  
Glen H Stanbaugh ◽  
A. W, Holmes Diane Gillit ◽  
George W. Reichel ◽  
Mark Stranz

A patient with end-stage renal disease on CAPD, and with massive iron overload is reported. This patient had evidence of myocardial and hepatic damage probably as a result of iron overload. Treatment with desferoxamine resulted in removal of iron in the peritoneal dialysate. On the basis of preliminary studies in this patient it would appear that removal of iron by peritoneal dialysis in conjunction with chelation therapy is safe and effective. This finding should have wide-ranging signficance for patients with ESRD.


Hemoglobin ◽  
2009 ◽  
Vol 33 (sup1) ◽  
pp. S58-S69 ◽  
Author(s):  
Maria D. Cappellini ◽  
Khaled M. Musallam ◽  
Ali T. Taher

2008 ◽  
Vol 54 (4) ◽  
pp. 503-507
Author(s):  
M. J. Pippard ◽  
S. T. Callender

Neurology ◽  
2015 ◽  
Vol 85 (12) ◽  
pp. 1085-1086 ◽  
Author(s):  
Francesco Bove ◽  
Alfonso Fasano

2017 ◽  
Vol 99 (5) ◽  
pp. 465-466 ◽  
Author(s):  
George J. Kontoghiorghes

2018 ◽  
Vol 93 (7) ◽  
pp. 943-952 ◽  
Author(s):  
Samir K. Ballas ◽  
Amer M. Zeidan ◽  
Vu H. Duong ◽  
Michelle DeVeaux ◽  
Matthew M. Heeney

Sign in / Sign up

Export Citation Format

Share Document